Literature DB >> 15249074

Liver echogenicity: measurement or visual grading?

Tapio Vehmas1, Ari Kaukiainen, Katariina Luoma, Martina Lohman, Markku Nurminen, Helena Taskinen.   

Abstract

OBJECTIVE: Two methods to assess liver echogenicity were compared.
METHODS: Liver/kidney echogenicity ratio was measured in 41 persons with the ultrasound software and visually graded by two radiologists and a radiographer. These echogenicity ratios and grades were related to risk factors for fatty liver and to liver enzyme levels.
RESULTS: These determinants explained 55% of the radiologists' mean grades, 14% of the radiographer's and 31% of the measured echogenicity ratios.
CONCLUSION: Radiologists' visual gradings correlated best with the indirect determinants of early liver pathology. Computerized measurements may be inferior to visual grading due to the lack of holistic tissue diagnostics.

Entities:  

Mesh:

Year:  2004        PMID: 15249074     DOI: 10.1016/j.compmedimag.2004.03.003

Source DB:  PubMed          Journal:  Comput Med Imaging Graph        ISSN: 0895-6111            Impact factor:   4.790


  4 in total

1.  Evaluation of diffuse liver steatosis by ultrasound, computed tomography, and magnetic resonance imaging: which modality is best?

Authors:  Aliya Qayyum; Daryl M Chen; Richard S Breiman; Antonio C Westphalen; Benjamin M Yeh; Kirk D Jones; Ying Lu; Fergus V Coakley; Peter W Callen
Journal:  Clin Imaging       Date:  2009 Mar-Apr       Impact factor: 1.605

2.  Silymarin in non alcoholic fatty liver disease.

Authors:  Fulvio Cacciapuoti; Anna Scognamiglio; Rossella Palumbo; Raffaele Forte; Federico Cacciapuoti
Journal:  World J Hepatol       Date:  2013-03-27

3.  Quantitative diagnostic method for biceps long head tendinitis by using ultrasound.

Authors:  Shih-Wei Huang; Wei-Te Wang
Journal:  ScientificWorldJournal       Date:  2013-12-07

4.  Obese Children with Metabolic Syndrome Have 3 Times Higher Risk to Have Nonalcoholic Fatty Liver Disease Compared with Those without Metabolic Syndrome.

Authors:  Dimitrios Papandreou; Mirey Karavetian; Zacharoula Karabouta; Eleni Andreou
Journal:  Int J Endocrinol       Date:  2017-10-08       Impact factor: 3.257

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.